Filter By Category
Archives
ASOPRISNIL
Generic Name: ASOPRISNIL
ABSTRACT -
Asoprisnil is a synthetic selective progesterone receptor modulator investigated for gynecologic disorders such as uterine fibroids and heavy menstrual bleeding. It exhibits mixed progesterone agonist/antagonist activity. Development was limited by concerns about endometrial changes and long-term safety, so it is not a routine approved therapy.
DOSAGE -
No approved standard dosage is available. Clinical studies evaluated oral daily dosing under protocol conditions. It should not be used outside specialist research or regulatory-authorized settings.
SIDE EFFECTS–
- Possible or reported side effects may include:
- Hot flushes
- Headache
- Abdominal or pelvic pain
- Breast tenderness
- Nausea
- Changes in uterine bleeding pattern or amenorrhea
- Endometrial changes
- Liver enzyme abnormalities are a class concern
ALLERGIC REACTIONS -
Hypersensitivity may include rash, hives, swelling, or breathing difficulty.
DRUG INTERACTIONS-
Use caution with:
- Hormonal contraceptives and other sex-hormone therapies
- CYP3A inhibitors or inducers if relevant
- Anticoagulants when abnormal uterine bleeding occurs
- Hepatotoxic medicines
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTIONS–
- Exclude pregnancy before use.
- Assess liver function, gynecologic diagnosis, endometrial status, and bleeding pattern.
- Use contraception as directed by protocol.
WARNINGS –
- Not approved for routine treatment of fibroids or endometriosis.
- Report severe abdominal pain, jaundice, heavy bleeding, or allergic symptoms immediately.
- Keep out of reach of children.
- In case of overdose, severe reaction, or clinical deterioration, seek immediate medical attention.



. Developed by